Decentralized Infectious Disease Testing Market Growth is Propelled by Increasing Trend of Patient Centric Care and Rising Incidences of Infectious Diseases

With developing technological innovations in the health care sector comprising biosensors, smartphone apps, lab-on-chip and tech tops, that offer a nearer association with the patient. Decentralized testing techniques are therefore becoming a catalyst in the transformation of the health care sector. The main reason that this type of testing is trending nowadays is because of its access and quicker results. It can be done closer to the patient, the results are convenient and quicker to the provider to further rush for the diagnosis and treatment. Decentralized infectious testing lets faster clinical decisions at the physician’s clinic, ambulance, and home. Decentralized testing can make a difference in the treatment of the patient. As this testing system is portable and moving it to the site of the patient, increases the chances of the physician, patient and the care team to have faster results and immediate decision making.

Browse through Decentralized Infectious Disease Testing Market report to know what factors will shape the market by 2024: http://www.transparencymarketresearch.com/decentralized-infectious-disease-testing-market.html

The demand for decentralized testing is increasing due to rising incidences of infectious diseases in developing countries. The increasing usage of decentralized testing and technological innovations with respect to ease of use and faster testing devices are encouraging the usage of decentralized testing. The decentralized testing market has professional and patient friendly or self-monitored testing like food pathogens, hematology, infectious diseases, coagulation test and urine analysis. Rapid results and first hand treatment reduces the downstream costs. As the conventional health care sector shifts to modern health care, more services can be presented to the patients at the decentralized testing of the patient.

The factors driving the trend of decentralized infectious disease testing include increasing trend of patient centric care, technological innovations, shortage of laboratory staff, increasing aging population, and rising incidences of infectious diseases. Even the diagnostic laboratories are also transforming on the basis of this format, where complex tests are performed in core labs and decentralized testing is performed in clinics, outpatient clinics or at patients home. This improves quality of care and access of care to the geriatric population. Advancements in the technology have been made such that it can be performed even by moderately trained staff. Many tests require labs for testing but now can be performed at the point of care. Another factor which drives the decentralized infectious disease testing market is the lack of trained staff in the laboratories. With less trained laboratory staff, drives the labs towards automated testing procedures and towards minimal user interaction systems. Thus, factors such as reduced sample volume, less specimen processing, shorter hospital stay, optimized medicine treatment and less post-operative care time support the growth of decentralized infectious disease testing market.

The decentralized infectious disease testing gives results for over 75 type of infectious diseases across varied testing platforms which include advanced technology laboratory equipment along with rapid diagnostic tests that can provide results for individual patients in less than or equal to 5 minutes. Infectious diseases such as malaria, measles, mumps, rubella, herpes simplex virus, cytomegalovirus, dengue fever, HIV and many more, can be detected through decentralized infectious disease testing procedures.

Briefly, North America has more options and a bigger share in the decentralized infectious disease testing market followed by Europe. With improved infrastructure and increasing awareness the global decentralized infectious disease testing market will have a boost in emerging countries of Asia Pacific. The prominent players having presence in the global decentralized infectious disease testing market are Becton-Dickinson and Company, Abbott Laboratories, Beckman Coulter, Inc., Siemens Medical Solutions, Nipro Diagnostics and Johnson & Johnson.

Request a sample of this report to know what opportunities will emerge in the rapidly evolving Decentralized Infectious Disease Testing Market by 2024: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14177

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.